Home / Insights / $20m in financing for blood-based bowel cancer test

$20m in financing for blood-based bowel cancer test

22 March 2016

Share

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

Share

$20m in financing for blood-based bowel cancer test

You may also like

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

Clinical Genomics hits a milestone in colon cancer prevention

Clinical Genomics Strenghtens it’s Leadership Team with Multiple Key Appointments

Ventured. Gained.